Successful, we will reply to you quickly.OK
Please select the quantity.OK
Your message is being sent, please wait.Close
Send mail failed, please send again!Close
Products are for research use only. Not for human use. We do not sell to patients.
(PP1 Analog II; 1-NM-PP 1)
1-NM-PP1 Chemical Structure
|Product name: 1-NM-PP1|
|Cat. No.: HY-13942|
1NM-PP1(PP1 Analog II) is a cell-permeable PP1 analog that acts as a potent and selective inhibitor of mutant kinases over their wild-type progenitors(IC50=28 uM vSrc; 4.2 nM v-Src-as1 I338G).
IC50 Value: 4.2 nM (v-Src-as1 I338G) 
Target: Src Family Kinase
PP1 Analog II, 1NM-PP1 is a cell-permeable PP1 analog that acts as a potent and selective inhibitor of mutant kinases over their wild-type progenitors. 1-NM-PP1 is a cell permeable inhibitor of kinases that have been mutated, by a single base substitution, to become 'analog sensitive', as compared to the wild-type kinase. 1-NM-PP1 was first developed to optimally inhibit v-Src-as1, with an I338G substitution, preferentially over v-Src (IC50 = 4.2 nM versus 28 μM, respectively). The homologous mutation in other kinases generated similar analog sensitivity (e.g., IC50 = 3.2 nM for c-Fyn-as1 versus 1.0 μM for c-Fyn; 5.0 nM for CDK2-as1 versus 29 μM for CDK2; 8.0 nM for CAMKII-as1 versus 24 μM for CAMKII). This approach has been used to elucidate functions of several kinases in both mammalian and yeast systems. In addition it has been shown to activate mutants of Ire1, a transmembrane kinase.
|M.Wt||331.41||Storage||Please store the product under the recommended conditions in the Certificate of Analysis.|
|Solvent & Solubility||
DMSO: ≤ 27.5 mg/mL
|1 mg||5 mg||10 mg|
|1 mM||3.0174 mL||15.0871 mL||30.1741 mL|
|5 mM||0.6035 mL||3.0174 mL||6.0348 mL|
|10 mM||0.3017 mL||1.5087 mL||3.0174 mL|
A-770041 is selective and orally active Src-family Lck inhibitor; A-770041 is a 147 nM inhibitor of Lck (1 mM ATP) and is 300-fold selective against Fyn, the other Src family kinase involved in T-cell signaling.
AMG-47a is a potent inhibitor of Lck and T cell proliferation; exhibits anti-inflammatory activity (ED50 = 11 mg/kg) in the anti-CD3 induced production of IL-2 in mice.
AZM475271 is a potent and selective Src kinase inhibitor with IC50 of 5 nM; no inhibitory activity on Flt3, KDR, Tie-2.
Bosutinib is Src family kinase inhibitor. Bosutinib inhibited migration of breast cancer cell lines with IC50 values of 0.1 to 0.3 umol/L.
CPDA is a novel potent SHIP2 inhibitor that can effectively ameliorate insulin resistance in 3T3-L1 adipocytes.
KX1-004 is a potent small molecule inhibitor of Src-PTK as a potential protective drug for NIHL.
MCB-613 is a potent, pan steroid receptor coactivator (SRC) stimulator.
MNS is a potent and selective inhibitor of Src and Syk tyrosine kinases.
PD173955 is src family-selective tyrosine kinase inhibitor with IC50 of ~22 nM for Src, Yes and Abl kinase; less potent for FGFR(alpha) and no activity on InsR and PKC.
PP1(AGL 1872) is a potent and selective Src inhibitor for Lck/Fyn with IC50 of 5 nM/ 6 nM.